AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …

Aims Thromboembolic risk stratification schemes and clinical guidelines for atrial fibrillation
(AF) regard risk as independent of classification into paroxysmal (PAF) and non-paroxysmal …

Patients with chronic kidney disease (CKD) are predisposed to heart rhythm disorders,
including atrial fibrillation (AF)/atrial flutter, supraventricular tachycardias, ventricular …

Background Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of
stroke. Medical therapy for decreasing stroke risk involves anticoagulation, which may …

Importance Atrial fibrillation is a potent risk factor for stroke, but whether the burden of atrial
fibrillation in patients with paroxysmal atrial fibrillation independently influences the risk of …

Importance Atrial fibrillation (AF) is associated with an increase in mortality and morbidity,
with a substantial increase in stroke and systemic thromboembolism. Strokes related to AF …

While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …